Physician profile
John D Overbeck
NPI 1508865536
$2,635.83
in general payments reported to CMS, 2019-2025
22 companies · $534 in 2025
The $534 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.78 · 2022: $265 · 2023: $840 · 2024: $980 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,353.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $512.21 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $466.85 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $296.29 | 2023-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $225.46 | 2022-2024 | Jardiance |
| Abbott Laboratories | $146.44 | 2024 | Aveir |
| E.R. Squibb & Sons, L.L.C. | $137.26 | 2022-2025 | Eliquis, Camzyos |
| Medtronic, INC. | $129.26 | 2022-2023 | Venaseal |
| Sanofi-Aventis U.S. LLC | $124.10 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $104.19 | 2022-2023 | Verquvo |
| Amgen INC. | $96.99 | 2022-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $69.92 | 2024 | Watchman Flx |
| Heartflow, INC. | $61.54 | 2023-2024 | Ffrct |
| Janssen Pharmaceuticals, INC | $45.16 | 2023 | Xarelto |
| Edwards Lifesciences Corporation | $44.44 | 2020-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novo Nordisk INC | $31.40 | 2025 | Wegovy |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $25.37 | 2024 | Cleviprex, Kengreal |
| Bayer Healthcare Pharmaceuticals INC. | $24.56 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.40 | 2022-2024 | Lifevest |
| Scpharmaceuticals INC. | $21.57 | 2025 | |
| Cvrx, INC. | $19.19 | 2024 | Barostim Neo System |
| Philips North America LLC | $16.03 | 2025 | Event |
| Bard Peripheral Vascular, INC. | $15.20 | 2023 | Venclose Maven Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Overbeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.